Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Adam H Schechter. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Adam H Schechter har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:DVA / DaVita Inc. | Director | 4 699 |
US:LH / Labcorp Holdings Inc. | President & CEO, Director | 93 319 |
US:MRK / Merck & Co., Inc. | EVP & Pres-Global Human Health | 0 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Adam H Schechter. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Adam H Schechter som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 369 | 4 699 | 8,52 | ||||
2025-08-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −5 643 | 93 319 | −5,70 | 266,78 | −1 505 440 | 24 895 643 |
2025-05-16 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 348 | 4 330 | 8,74 | ||||
2025-05-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 105 | 98 962 | −5,81 | 248,73 | −1 518 497 | 24 614 818 |
2025-03-31 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −13 584 | 105 067 | −11,45 | 231,67 | −3 147 005 | 24 340 872 | |
2025-03-31 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
A - Award | 30 469 | 118 651 | 34,55 | ||||
2025-03-18 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 349 | 3 982 | 9,61 | ||||
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 226 | 88 182 | −1,37 | 245,14 | −300 542 | 21 616 935 | |
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 2 963 | 89 408 | 3,43 | ||||
2025-02-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 121 | 86 445 | −6,61 | 244,62 | −1 497 319 | 21 146 176 |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 345 | 92 566 | −1,43 | 246,27 | −331 233 | 22 796 229 | |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 3 250 | 93 911 | 3,58 | ||||
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
F - Taxes | −1 240 | 90 661 | −1,35 | 247,74 | −307 198 | 22 460 356 | |
2025-02-10 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
M - Exercise | 4 460 | 91 901 | 5,10 | ||||
2024-11-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 312 | 3 633 | 9,39 | ||||
2024-11-13 |
|
4 | LH |
LABCORP HOLDINGS INC.
Common Stock |
S - Sale | X | −6 189 | 87 441 | −6,61 | 243,47 | −1 506 836 | 21 289 260 |
2024-08-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 333 | 3 321 | 11,14 | ||||
2024-05-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 363 | 2 988 | 13,83 | ||||
2024-03-29 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −31 799 | 93 630 | −25,35 | 216,57 | −6 886 709 | 20 277 449 | |
2024-03-29 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 72 435 | 125 429 | 136,69 | ||||
2024-03-19 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 366 | 2 625 | 16,20 | ||||
2024-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 231 | 52 994 | −2,27 | 227,45 | −279 991 | 12 053 485 | |
2024-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 964 | 54 225 | 5,78 | ||||
2024-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 149 | 51 261 | −2,19 | 223,71 | −257 043 | 11 467 598 | |
2024-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 250 | 52 410 | 6,61 | ||||
2024-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −822 | 49 160 | −1,64 | 221,54 | −182 106 | 10 890 906 | |
2024-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 094 | 49 982 | 6,60 | ||||
2023-11-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 529 | 2 259 | 30,58 | ||||
2023-08-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 475 | 1 730 | 37,85 | ||||
2023-05-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 516 | 1 255 | 69,82 | ||||
2023-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −18 646 | 46 888 | −28,45 | 224,70 | −4 189 756 | 10 535 734 | |
2023-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
A - Award | 42 353 | 65 534 | 182,71 | ||||
2023-03-17 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 658 | 739 | 812,35 | ||||
2023-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 170 | 23 181 | −4,80 | 248,13 | −290 312 | 5 751 902 | |
2023-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 656 | 24 351 | 12,24 | ||||
2023-02-07 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 368 | 21 695 | −5,93 | 244,50 | −334 476 | 5 304 428 | |
2023-02-07 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 507 | 23 063 | 17,93 | ||||
2023-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −805 | 19 556 | −3,95 | 254,99 | −205 267 | 4 986 584 | |
2023-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 773 | 20 361 | 15,77 | ||||
2022-11-16 |
|
4 | DVA |
DAVITA INC.
Common Stock |
A - Award | 81 | 81 | |||||
2022-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −893 | 17 588 | −4,83 | 222,56 | −198 746 | 3 914 385 | |
2022-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 007 | 18 481 | 12,18 | ||||
2022-09-29 | 3 | DVA |
DAVITA INC.
No securities are beneficially owned |
0 | ||||||||
2022-02-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 28 100 | 28 100 | |||||
2022-02-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 7 970 | 19 031 | 72,05 | ||||
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −3 507 | 11 061 | −24,07 | ||||
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 412 | 16 474 | −7,89 | 277,48 | −391 802 | 4 571 206 | |
2022-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 507 | 17 886 | 24,39 | ||||
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 773 | 14 568 | −15,99 | ||||
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −803 | 14 379 | −5,29 | 273,18 | −219 364 | 3 928 055 | |
2022-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 773 | 15 182 | 22,35 | ||||
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 007 | 17 341 | −10,37 | ||||
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −886 | 12 409 | −6,66 | 288,78 | −255 859 | 3 583 471 | |
2021-11-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 007 | 13 295 | 17,78 | ||||
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −3 506 | 19 348 | −15,34 | ||||
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −1 028 | 11 288 | −8,35 | 223,78 | −230 046 | 2 526 029 | |
2021-02-08 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 3 506 | 12 316 | 39,80 | ||||
2021-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 29 000 | 29 000 | |||||
2021-02-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 8 320 | 22 854 | 57,25 | ||||
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −2 006 | 14 534 | −12,13 | ||||
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
F - Taxes | −885 | 8 810 | −9,13 | 207,23 | −183 399 | 1 825 696 | |
2020-11-04 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 2 006 | 9 695 | 26,09 | ||||
2020-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 227 | 16 540 | −6,91 | ||||
2020-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 227 | 7 689 | 18,99 | ||||
2020-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 45 600 | 45 600 | |||||
2020-02-06 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 10 520 | 17 767 | 145,16 | ||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 65 100 | 65 100 | |||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Non-qualified Stock Options |
A - Award | 24 800 | 24 800 | |||||
2019-11-05 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 6 020 | 7 247 | 490,63 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 227 | 1 227 | |||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 038 | 0 | −100,00 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 038 | 6 462 | 19,14 | ||||
2019-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
G - Gift | −610 | 5 424 | −10,11 | ||||
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −277 879 | 0 | −100,00 | ||||
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −145 135 | 0 | −100,00 | 73,66 | −10 691 181 | |
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −132 744 | 145 135 | −47,77 | 73,98 | −9 819 764 | 10 736 391 |
2018-11-02 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 277 879 | 277 879 | 39,29 | 10 917 866 | 10 917 866 | ||
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −100 000 | 0 | −100,00 | ||||
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −7 360 | 55 406 | −11,73 | 70,18 | −516 511 | 3 888 286 |
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −100 000 | 0 | −100,00 | 70,18 | −7 017 780 | |
2018-09-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 100 000 | 100 000 | 36,56 | 3 656 000 | 3 656 000 | ||
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −100 000 | 100 000 | −50,00 | ||||
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −34 094 | 62 766 | −35,20 | 61,00 | −2 079 785 | 3 828 819 |
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −100 000 | 0 | −100,00 | 61,00 | −6 100 160 | |
2018-06-19 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 100 000 | 100 000 | 36,56 | 3 656 000 | 3 656 000 | ||
2018-05-08 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 139 063 | 139 063 | |||||
2018-03-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 34 094 | 34 094 | 54,72 | 1 865 624 | 1 865 624 | ||
2018-02-14 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 038 | 1 038 | |||||
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
S - Sale | X | −1 263 | 6 034 | −17,31 | 169,29 | −213 813 | 1 021 496 |
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 263 | 0 | −100,00 | ||||
2018-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 263 | 7 297 | 20,93 | ||||
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 994 | 200 000 | −20,32 | ||||
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 608 | 62 766 | −44,64 | 61,63 | −3 118 971 | 3 868 267 |
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 994 | 0 | −100,00 | 61,63 | −3 142 760 | |
2018-01-16 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 994 | 50 994 | 36,56 | 1 864 341 | 1 864 341 | ||
2017-12-18 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
G - Gift | −750 | 113 374 | −0,66 | ||||
2017-05-09 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 162 625 | 162 625 | |||||
2017-04-10 |
|
4/A | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 37 758 | 37 758 | 65,85 | 2 486 364 | 2 486 364 | ||
2017-04-04 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −53 850 | 116 336 | −31,64 | 63,48 | −3 418 166 | 7 384 507 |
2017-03-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 39 970 | 39 970 | 65,85 | 2 632 024 | 2 632 024 | ||
2017-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 560 | 1 263 | −55,26 | ||||
2017-02-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 560 | 6 034 | 34,87 | ||||
2017-02-09 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 263 | 2 823 | 80,96 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −26 135 | 0 | −100,00 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −10 200 | 250 994 | −3,91 | ||||
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −36 335 | 0 | −100,00 | 63,73 | −2 315 699 | |
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 10 200 | 36 335 | 39,03 | 36,56 | 372 912 | 1 328 408 | |
2017-02-06 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 26 135 | 26 135 | 33,49 | 875 261 | 875 261 | ||
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −39 200 | 26 135 | −60,00 | ||||
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −39 200 | 0 | −100,00 | 62,61 | −2 454 308 | |
2016-09-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 39 200 | 39 200 | 33,49 | 1 312 808 | 1 312 808 | ||
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −50 000 | 0 | −100,00 | 57,69 | −2 884 415 | |
2016-07-01 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 44,30 | 2 215 000 | 2 215 000 | ||
2016-05-12 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 258 065 | 258 065 | |||||
2016-03-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 237 | 1 560 | −44,23 | ||||
2016-03-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 237 | 4 474 | 38,21 | ||||
2016-02-24 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 37 223 | 37 223 | 50,77 | 1 889 812 | 1 889 812 | ||
2016-02-11 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 560 | 2 797 | 126,11 | ||||
2015-05-11 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | −10 634 | 0 | −100,00 | 60,44 | −642 768 | ||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Restricted Stock Unit |
M - Exercise | −19 343 | 0 | −100,00 | 59,86 | −1 157 872 | ||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
F - Taxes | −8 709 | 10 634 | −45,02 | 59,86 | −521 321 | 636 551 | |
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 19 343 | 19 343 | |||||
2015-05-05 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
A - Award | 235 294 | 235 294 | |||||
2015-03-13 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 237 | 1 237 | |||||
2015-02-25 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
A - Award | 22 198 | 22 198 | 58,30 | 1 294 143 | 1 294 143 | ||
2015-02-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 503 | 0 | −100,00 | ||||
2015-02-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 503 | 3 237 | 86,68 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −19 200 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
S - Sale | X | −74 200 | 0 | −100,00 | 62,48 | −4 636 224 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 5 000 | 74 200 | 7,23 | 34,47 | 172 350 | 2 557 674 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 19 200 | 69 200 | 38,40 | 35,09 | 673 728 | 2 428 228 | |
2015-01-15 |
|
4 | MRK |
Merck & Co., Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 44,19 | 2 209 500 | 2 209 500 | ||
2014-11-25 |
|
4 | MRK |
Merck & Co. Inc.
Phantom Stock |
S - Sale | −2 779 | 0 | −100,00 | ||||
2014-08-25 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | X | −22 000 | 70 795 | −23,71 | 59,70 | −1 313 380 | 4 226 396 |
2014-05-15 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 503 | 1 503 | |||||
2014-05-14 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | X | −10 527 | 0 | −100,00 | 55,91 | −588 584 | |
2014-05-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 209 078 | 209 078 | |||||
2014-05-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
M - Exercise | −1 593 | 0 | −100,00 | ||||
2014-05-12 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
M - Exercise | 1 593 | 1 734 | 1 129,79 | 98,96 | 157 643 | 171 597 | |
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −19 147 | 0 | −100,00 | 58,22 | −1 114 738 | ||
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −8 620 | 10 527 | −45,02 | 58,22 | −501 856 | 612 882 | |
2014-05-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 19 147 | 19 147 | |||||
2014-02-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 22 287 | 22 287 | 56,18 | 1 252 084 | 1 252 084 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −3 000 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −12 500 | 0 | −100,00 | ||||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock - 401(k) Plan |
I - Other | −4 040 | 0 | −100,00 | 55,70 | −225 049 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | −18 000 | 0 | −100,00 | 55,61 | −1 000 935 | ||
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 2 500 | 18 000 | 16,13 | 47,39 | 118 475 | 853 020 | |
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 3 000 | 15 500 | 24,00 | 45,41 | 136 230 | 703 855 | |
2014-02-13 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 12 500 | 12 500 | 48,24 | 603 000 | 603 000 | ||
2013-05-16 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Restricted Stock Unit |
A - Award | 1 593 | 1 593 | |||||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −12 188 | 0 | −100,00 | 44,98 | −548 216 | ||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −5 488 | 22 416 | −19,67 | 44,98 | −246 850 | 1 008 252 | |
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 12 188 | 27 904 | 77,55 | ||||
2013-05-08 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 244 767 | 244 767 | |||||
2013-04-03 |
|
4 | LH |
LABORATORY CORP OF AMERICA HOLDINGS
Common Stock |
A - Award | 141 | 141 | |||||
2013-02-27 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 8 136 | 15 568 | 109,47 | 42,52 | 345 943 | 661 951 | |
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −10 670 | 0 | −100,00 | 41,42 | −441 951 | ||
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −3 238 | 7 432 | −30,35 | 41,42 | −134 118 | 307 833 | |
2013-02-20 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 10 670 | 10 670 | |||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
M - Exercise | −61 200 | 0 | −100,00 | ||||
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
S - Sale | −56 300 | 14 900 | −79,07 | 45,60 | −2 567 257 | 679 434 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 5 000 | 71 200 | 7,55 | 28,42 | 142 100 | 2 023 504 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 5 000 | 66 200 | 8,17 | 31,84 | 159 200 | 2 107 808 | |
2012-11-06 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 61 200 | 61 200 | 23,45 | 1 435 140 | 1 435 140 | ||
2012-05-04 |
|
4 | MRK |
Merck & Co. Inc.
Stock Option (right to buy) |
A - Award | 277 879 | 277 879 | |||||
2012-05-04 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
A - Award | 19 343 | 19 343 | |||||
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Restricted Stock Unit |
M - Exercise | −11 475 | 0 | −100,00 | 38,27 | −439 148 | ||
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
F - Taxes | −4 535 | 7 035 | −39,20 | 38,27 | −173 554 | 269 226 | |
2012-04-26 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
M - Exercise | 11 475 | 11 570 | 12 089,51 | ||||
2012-03-01 |
|
4 | MRK |
Merck & Co. Inc.
Common Stock |
A - Award | 9 194 | 9 194 | 38,38 | 352 866 | 352 866 | ||
2010-05-06 | 3 | MRK |
Merck & Co. Inc.
Common Stock - 401(k) Plan |
9 804 |